The small, shrooms canada known as shrooms canada contain a hallucinogenic drug called psilocybin. Traditionally, they’ve been illegal in Canada to pick and sell without a licence. But a few years ago, the mushrooms started popping up in back alleys across the country. And now, they’re getting a lot more attention. Last year, articles in the New York Times and Forbes introduced “microdosing” — low-dose self-medication of psychedelic drugs like magic mushrooms — to a wider audience. Since then, Google searches for the term have doubled.

Guide to Golden Teacher Mushrooms: A Psychedelic Journey in Canada

The trend has caught the attention of entrepreneurs and researchers. There is a growing interest in microdosing to treat depression, and a renewed interest in psilocybin (the active ingredient in magic mushrooms) as a treatment for anxiety and other mental health conditions.

Despite their recent popularity, psilocybin is still a Schedule III drug under the Controlled Drugs and Substances Act. That means a person can only possess or sell them with an exemption from Health Canada, such as through a Special Access Program request.

But a few private companies are pushing the boundaries. At one Vancouver-based business, Filament Health, employees have started taking psychedelics such as MDMA and psilocybin with their patients in hopes that it will help them overcome serious mental health conditions. A co-founder says the idea is to use these substances as a tool for healing, rather than simply to get high. He points to a study published in Nature last year, which found that people who took psilocybin and LSD as part of a therapeutic process were more likely to report better quality of life after the experience than those who used them just to get high.